rofecoxib has been researched along with Thrombopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, S | 1 |
| Tambar, S | 1 |
| Chohan, S | 1 |
| Ramsey-Goldman, R | 1 |
| Lee, C | 1 |
| Kentos, A | 1 |
| Robin, V | 1 |
| Lambermont, M | 1 |
| Jurdan, M | 1 |
| Pignarelli, M | 1 |
| Feremans, W | 1 |
2 other studies available for rofecoxib and Thrombopenia
| Article | Year |
|---|---|
Acute myocardial infarction after treatment of thrombocytopenia in a young woman with systemic lupus erythematosus.
Topics: Antibodies, Antiphospholipid; Cyclooxygenase Inhibitors; Female; Humans; Immunoglobulins, Intravenou | 2008 |
Probable rofecoxib-induced thrombocytopenia.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cycloo | 2003 |